Anticipating Annex XIV listing and its impact on the market
Substances included in the recommendation: impact on marketing

Recommended substances are included in Annex XIV by decision of the European Commission, which may however modify the content of the recommendation (addition or withdrawal of a substance, modification of transitional provisions, etc.).

Annex XIV is amended at least every two years. It defines :

• the name of the substances and their CE and CAS identification numbers;

• hazard properties used for SVHC identification ;

• transitional provisions such as the expiry date and the deadline for filing an application for authorization to avoid any interruption in use;

• any exempted uses and corresponding revision periods.

Once included in Annex XIV, a substance may not be placed on the market or...